New multifocal IOLs

New multifocal IOLs

Abbott has announced the European launch of two new measurements (optical add powers) for the TECNIS® Multifocal intraocular lens (IOL), which the company says will provide more customised treatment options for cataract patients. “With the addition of these TECNIS Multifocal IOLs, Abbott is able to provide physicians the ability to offer a more precise lens option for their patients, allowing them to maintain quality vision at near, intermediate and far distances,” said a company spokesman. “The TECNIS Multifocal +2.75 add power IOL is suited for patients who prefer intermediate vision activities, such as seeing an automobile dashboard. The TECNIS Multifocal +3.25 add power IOL is suited for patients favouring activities at longer reading distances such as working at a computer, while still providing a full range of vision,” he said.

 www.abbott.com

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...